(THLD:Consolidated Issue listed on NASDAQ Capital Market)
Tillman E. Pearce M.D.
Chief Medical Officer, Threshold Pharmaceuticals Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
As of Fiscal Year 2014
Dr. Tillman E. Pearce, M.D., has been the Chief Medical Officer at Threshold Pharmaceuticals Inc since February 17, 2012. Dr. Pearce oversees the development of Threshold's TH-302, a clinical stage hypoxia-targeted cancer therapeutic being evaluated in a variety of cancers, including a Phase 3 trial in patients with soft tissue sarcoma and a Phase 2b trial in patients with pancreatic cancer. Dr. Pearce has almost two decades of international experience in drug development, ...
170 Harbor WayPhone: 650-474-8200
South San Francisco, California 94080
Board Members Memberships*There is no Board Members Memberships data available.
Medical College Of Georgia
|There is no Competitor Compensation data available.|